Half: Good point. Abbott is there to take this baby to market and it may be sooner than we all expect.
I also liked the part where Drs. Moro and or Wittenberg talked about using the precedent of ADML or AMDL. You know what I'm talking about. Marketing appears to be high on their list now which is probably how it should have been from the onset.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.